Efavirenz use during pregnancy and for women of child-bearing potential

Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is ter...

Full description

Bibliographic Details
Main Authors: Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Format: Article
Language:English
Published: BMC 2006-04-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/3/1/11

Internet

http://www.aidsrestherapy.com/content/3/1/11

Similar Items